Synopsys Valuation
| SNPS Stock | USD 437.31 0.22 0.05% |
At this time, the company appears to be undervalued. Synopsys has a current Real Value of $491.55 per share. The regular price of the company is $437.31. Our model measures the value of Synopsys from inspecting the company fundamentals such as Return On Equity of 0.0716, shares outstanding of 191.32 M, and Operating Margin of 0.05 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Synopsys' valuation include:
Price Book 2.952 | Enterprise Value | Enterprise Value Ebitda 37.9777 | Price Sales 11.8544 | Forward PE 30.4878 |
Undervalued
Today
Please note that Synopsys' price fluctuation is very steady at this time. Calculation of the real value of Synopsys is based on 3 months time horizon. Increasing Synopsys' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Synopsys stock is determined by what a typical buyer is willing to pay for full or partial control of Synopsys. Since Synopsys is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Synopsys Stock. However, Synopsys' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 437.31 | Real 491.55 | Target 557.0 | Hype 437.76 |
The intrinsic value of Synopsys' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Synopsys' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Synopsys helps investors to forecast how Synopsys stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Synopsys more accurately as focusing exclusively on Synopsys' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Synopsys' intrinsic value based on its ongoing forecasts of Synopsys' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Synopsys' closest peers.
Synopsys Cash |
|
Synopsys Revenue by Product
Synopsys Total Value Analysis
Synopsys is at this time projected to have valuation of 94.96 B with market capitalization of 83.62 B, debt of 14.29 B, and cash on hands of 1.53 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Synopsys fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
94.96 B | 83.62 B | 14.29 B | 1.53 B |
Synopsys Investor Information
About 90.0% of the company shares are owned by institutional investors. The book value of Synopsys was at this time reported as 152.3. The company has Price/Earnings To Growth (PEG) ratio of 2.74. Synopsys recorded earning per share (EPS) of 8.09. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 24th of September 2003. Based on the key indicators related to Synopsys' liquidity, profitability, solvency, and operating efficiency, Synopsys is not in a good financial situation at the present time. It has a very high chance of going through financial crunch in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.11 | 0.12 |
|
| |||||
| Total Cash From Operating Activities | 1.8 B | 1.7 B |
|
| |||||
| Operating Income | 1.1 B | 1.1 B |
|
|
Synopsys Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Synopsys has an asset utilization ratio of 14.63 percent. This implies that the Company is making $0.15 for each dollar of assets. An increasing asset utilization means that Synopsys is more efficient with each dollar of assets it utilizes for everyday operations.Synopsys Profitability Analysis
Based on Synopsys' profitability indicators, Synopsys may not be well positioned to generate adequate gross income at the present time. It has a very high chance of underperforming in March. Profitability indicators assess Synopsys' ability to earn profits and add value for shareholders.Net Income | First Reported 1989-10-31 | Previous Quarter 242.5 M | Current Value 448.7 M | Quarterly Volatility 135 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.91 | 0.89 |
|
| |||||
| Net Profit Margin | 0.096 | 0.17 |
|
| |||||
| Operating Profit Margin | 0.11 | 0.12 |
|
| |||||
| Pretax Profit Margin | 0.12 | 0.18 |
|
| |||||
| Return On Assets | 0.0302 | 0.0318 |
|
| |||||
| Return On Equity | 0.0514 | 0.0541 |
|
|
For Synopsys profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Synopsys to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Synopsys utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Synopsys's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Synopsys over time as well as its relative position and ranking within its peers.
Synopsys Earnings per Share Projection vs Actual
The next projected EPS of Synopsys is estimated to be 3.604375 with future projections ranging from a low of 3.555 to a high of 3.860775. Synopsys' most recent 12-month trailing earnings per share (EPS TTM) is at 8.09. Please be aware that the consensus of earnings estimates for Synopsys is based on EPS before non-recurring items and includes expenses related to employee stock options.Synopsys Earnings Estimation Breakdown
The calculation of Synopsys' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Synopsys is estimated to be 3.604375 with the future projection ranging from a low of 3.555 to a high of 3.860775. Please be aware that this consensus of annual earnings estimates for Synopsys is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
3.56 Lowest | Expected EPS | 3.86 Highest |
Synopsys Earnings Projection Consensus
Suppose the current estimates of Synopsys' value are higher than the current market price of the Synopsys stock. In this case, investors may conclude that Synopsys is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Synopsys' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of October 2026 | Current EPS (TTM) | |
| 25 | 89.83% | 0.0 | 3.604375 | 8.09 |
Synopsys Ownership Allocation
Synopsys shows a total of 191.32 Million outstanding shares. The majority of Synopsys outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Synopsys to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Synopsys. Please pay attention to any change in the institutional holdings of Synopsys as this could imply that something significant has changed or is about to change at the company. On January 16, 2026, Representative Dan Newhouse of US Congress acquired under $15k worth of Synopsys's common stock.Synopsys Profitability Analysis
The company reported the previous year's revenue of 7.05 B. Net Income was 1.33 B with profit before overhead, payroll, taxes, and interest of 5.74 B.About Synopsys Valuation
The stock valuation mechanism determines Synopsys' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Synopsys based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Synopsys. We calculate exposure to Synopsys's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Synopsys's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.2 B | 6.6 B | |
| Pretax Profit Margin | 0.18 | 0.12 | |
| Operating Profit Margin | 0.12 | 0.11 | |
| Net Profit Margin | 0.17 | 0.10 | |
| Gross Profit Margin | 0.89 | 0.91 |
Synopsys Quarterly Retained Earnings |
|
Synopsys Growth Indicators
Investing in growth stocks can be very risky. If the company such as Synopsys does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 161.7 M | |
| Quarterly Earnings Growth Y O Y | -0.665 | |
| Forward Price Earnings | 30.4878 |
Synopsys Current Valuation Indicators
Synopsys' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Synopsys' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Synopsys, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Synopsys' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Synopsys' worth.Additional Tools for Synopsys Stock Analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.